Landmark Hospitalist Trial: Why Aspirin May Be Harmful in Patients Already Taking Blood Thinners

Aspirin is one of the most familiar medications in medicine.

Anticoagulants are also routinely prescribed to reduce thromboembolic risk in conditions such as atrial fibrillation and venous thromboembolism.

But what happens when a patient is taking both aspirin and an anticoagulant?

For hospitalists, this is an important medication-reconciliation question because combining antiplatelet and anticoagulant therapy can increase bleeding risk. In some patients, there is a clear clinical reason to use both. In others, aspirin may remain on the medication list even when its ongoing indication is uncertain.

The practical question is therefore not:

“Should aspirin and anticoagulants never be used together?”

It is:

“Does this patient still have a clear indication for aspirin in addition to anticoagulation?”

That distinction matters.

Why Hospitalists Should Pay Attention to Aspirin and Anticoagulation

Hospitalists frequently care for patients taking anticoagulants.

Common indications include:

• Atrial fibrillation
• Deep vein thrombosis
• Pulmonary embolism
• Other thromboembolic conditions

At the same time, many hospitalized patients also arrive with aspirin on their outpatient medication list.

Sometimes the reason is obvious.

The patient may have a cardiovascular indication for antiplatelet therapy, and in certain circumstances combined therapy may be appropriate.

But sometimes the reason is less clear.

Aspirin may have been started years earlier. The original indication may no longer apply. The patient’s cardiovascular treatment may have changed. Or aspirin may simply have remained on the medication list through multiple transitions of care.

That creates an important opportunity for medication review.

For hospitalists, anticoagulation management is one example of why staying current with evolving evidence is so important. Hospitalist CME can provide structured opportunities to review changing evidence, guidelines, and practical inpatient-management strategies.

Aspirin and Anticoagulants Do Different Things

It is useful to remember that aspirin and anticoagulants affect thrombosis through different mechanisms.

Aspirin is an antiplatelet medication. It reduces platelet activation and aggregation.

Anticoagulants interfere with components of the coagulation cascade.

Common oral anticoagulants include medications such as:

• Apixaban
• Rivaroxaban
• Dabigatran
• Edoxaban
• Warfarin

Because antiplatelet and anticoagulant therapies target different parts of clot formation, combining them can produce a stronger antithrombotic effect.

That may be desirable in selected clinical situations.

But it can also increase bleeding risk.

Therefore, the presence of two antithrombotic medications on a patient’s list should prompt a simple but important question:

Why is this patient taking both?

The Important Clinical Issue: Benefit Versus Bleeding Risk

Medicine frequently requires balancing competing risks.

Antithrombotic therapy illustrates this particularly well.

Clinicians may be trying to reduce the risk of:

• Ischemic stroke
• Systemic embolism
• Recurrent venous thromboembolism
• Myocardial infarction
• Coronary thrombosis

At the same time, antithrombotic therapy can increase the risk of bleeding.

Potential bleeding complications may include:

• Gastrointestinal bleeding
• Intracranial hemorrhage
• Hematuria
• Post-procedural bleeding
• Anemia
• Other clinically significant bleeding

Adding aspirin to anticoagulation therefore should not be treated as a trivial medication decision.

If aspirin provides a meaningful additional benefit for a particular patient, the additional bleeding risk may be justified.

If aspirin does not provide meaningful additional benefit, however, exposing the patient to additional bleeding risk becomes much harder to justify.

Not Every Patient on an Anticoagulant Should Automatically Stop Aspirin

This point is critical.

Evidence showing increased bleeding with combination antithrombotic therapy does not mean every patient taking an anticoagulant should discontinue aspirin.

There are clinical situations in which antiplatelet therapy may still be indicated.

Depending on the patient’s circumstances, these can include certain patients with:

• Recent acute coronary syndrome
• Recent percutaneous coronary intervention
• Coronary stents
• Selected forms of established atherosclerotic cardiovascular disease
• Other cardiovascular indications

The appropriate regimen and duration depend on the patient’s specific diagnosis, procedure history, thrombotic risk, bleeding risk, and current evidence-based recommendations.

That means hospitalists should avoid replacing one oversimplification—

“Aspirin is good for the heart.”

—with another—

“Aspirin is bad if you’re taking an anticoagulant.”

Neither statement is sufficiently precise.

The right question is whether the individual patient has a current indication for combination therapy.

Why Medication Reconciliation Matters

Hospital admission creates an important opportunity to review medications.

A patient may arrive with a medication list accumulated over many years.

Some medications have clear current indications.

Others may have been started for reasons that are no longer obvious.

For every medication—particularly medications that carry meaningful risks—hospitalists should consider:

1. Why was this medication started?
2. Does the indication still exist?
3. Is the medication still providing meaningful benefit?
4. Has the patient’s risk profile changed?
5. Is another medication now duplicating part of its effect?
6. Could the medication be contributing to the current hospitalization?

Aspirin in a patient already receiving anticoagulation is a good example of why this process matters.

Medication reconciliation should be more than copying an outpatient medication list into the inpatient chart.

It should be a clinical review.

A Common Hospitalist Scenario

Consider a patient admitted with pneumonia.

The medication list includes:

• Apixaban
• Aspirin
• Metoprolol
• Atorvastatin
• Lisinopril

The patient has atrial fibrillation, which explains the apixaban.

But why aspirin?

Perhaps the patient had a coronary intervention recently.

Perhaps there is another established cardiovascular indication.

Or perhaps aspirin was started many years ago and simply never disappeared from the medication list.

The hospitalist should investigate.

That may require reviewing prior cardiology notes, procedure history, discharge summaries, medication records, and the patient’s recollection.

The point is not to discontinue aspirin automatically.

The point is to verify the indication.

Hospitalists Are Well Positioned to Identify Unnecessary Medication Risk

Hospitalists frequently inherit medication lists created by multiple clinicians across multiple settings.

That gives inpatient physicians a unique opportunity to identify potentially unnecessary or duplicative therapy.

The hospitalist sees:

• The current medical problem
• The patient’s complete medication list
• Laboratory data
• Renal function
• Hemoglobin trends
• Bleeding history
• Fall risk
• Current diagnoses
• Recent procedures
• Consultant recommendations

This broad perspective can make hospitalization an important moment for medication optimization.

The same principle applies beyond aspirin.

Hospitalists routinely reconsider medications such as:

• Anticoagulants
• Antiplatelet agents
• Antihypertensives
• Diabetes medications
• Sedatives
• Proton-pump inhibitors
• NSAIDs
• Supplements
• Medications affected by renal function

Hospital medicine is not only about starting treatment.

Sometimes improving care means recognizing when a treatment should be reconsidered.

Bleeding Risk Is Not the Same for Every Patient

The clinical consequences of adding antiplatelet therapy to anticoagulation also depend on the individual patient.

Factors that may influence bleeding risk include:

• Advanced age
• Previous bleeding
• History of gastrointestinal bleeding
• Renal dysfunction
• Liver disease
• Thrombocytopenia
• Anemia
• Concomitant medications
• Alcohol use
• Frailty
• Recent procedures
• Other comorbidities

A medication combination tolerated by one patient may create substantially greater risk in another.

This is why clinical decisions should not be based solely on the presence or absence of a medication.

The patient’s entire clinical context matters.

What About Patients With Atrial Fibrillation?

Atrial fibrillation is one of the most common reasons hospitalists encounter chronic oral anticoagulation.

For patients receiving anticoagulation for stroke prevention in atrial fibrillation, the discovery of concurrent aspirin should prompt review of the aspirin indication.

Does the patient have coronary artery disease?

Was there a recent acute coronary syndrome?

Has the patient undergone PCI?

When was the intervention?

What did cardiology recommend?

Has the intended period of combination therapy already passed?

Has the patient’s bleeding risk changed?

These questions are more clinically useful than assuming that two antithrombotic agents must always be better than one.

What About Patients With Venous Thromboembolism?

The same medication-review principle applies to patients anticoagulated for deep vein thrombosis or pulmonary embolism.

If aspirin also appears on the medication list, determine why.

The anticoagulant is being used for one thrombotic indication.

The aspirin may—or may not—have a separate reason.

Again, the issue isn’t automatically eliminating aspirin.

It is avoiding unnecessary combination antithrombotic therapy when there is no longer a compelling indication.

Communication at Discharge Is Essential

Medication changes made during hospitalization can create confusion if they are not communicated clearly.

Suppose a hospitalist determines, after appropriate review and discussion, that aspirin no longer appears necessary.

Simply removing it from the discharge medication list may not be enough.

The discharge documentation should make the reasoning clear when appropriate.

Patients should understand which medications they are taking and why.

Relevant outpatient clinicians should also be able to determine why a change occurred.

This is particularly important for antithrombotic medications because patients may have received different recommendations from different clinicians over time.

Transitions of care are therefore part of safe anticoagulation management.

Evidence-Based Medicine Requires More Than Reading the Headline

A study about aspirin and anticoagulation can easily generate a dramatic headline:

“Aspirin is dangerous with blood thinners.”

But that isn’t how clinicians should interpret medical evidence.

When reviewing a trial or observational study, ask:

• Who was studied?
• What anticoagulants were used?
• Why were patients anticoagulated?
• What dose of aspirin was used?
• Did participants have coronary artery disease?
• Were patients with recent PCI included or excluded?
• What was the primary outcome?
• How was major bleeding defined?
• Were ischemic outcomes different?
• How long were patients followed?
• Does this population resemble the patient in front of me?

A landmark study can change practice only when clinicians understand what the study actually demonstrated and to whom the findings apply.

This is one reason continuing medical education matters for hospitalists, physician assistants, and nurse practitioners. New evidence must be interpreted before it can be appropriately incorporated into clinical care.

The Broader Lesson: Deprescribing Is Part of Good Hospital Medicine

The aspirin-anticoagulation question illustrates a broader principle.

More medication is not always better medicine.

Hospitalists should periodically ask whether each treatment still has a clear indication.

Deprescribing does not mean indiscriminately stopping medications.

It means thoughtfully identifying therapies whose risks may now outweigh their benefits or whose original indication no longer applies.

This can be especially important in patients with:

• Polypharmacy
• Multiple chronic illnesses
• Renal dysfunction
• Recurrent falls
• Previous bleeding
• Frailty
• Frequent hospitalizations

Medication review can therefore be an important patient-safety intervention.

Clinical Pearl for Hospitalists

When you see aspirin + an anticoagulant on the medication list, don’t automatically continue both—and don’t automatically discontinue either.

Instead, ask:

What is the indication for the anticoagulant?

What is the indication for aspirin?

Is combination therapy still recommended for this patient’s current clinical situation?

How long was combination therapy intended to continue?

Has the patient’s bleeding risk changed?

Do I need to review previous cardiology or procedural records?

Would discussion with the patient’s cardiologist or another treating clinician help clarify the plan?

That approach turns medication reconciliation into clinical decision-making.

Why This Matters for Hospitalist Education

Anticoagulation is a perfect example of why hospital medicine requires continuous learning.

Recommendations evolve.

New anticoagulants become available.

Reversal strategies change.

Evidence surrounding antiplatelet and anticoagulant combinations develops.

Guidelines are updated.

Hospitalists therefore need more than memorized rules. They need a framework for interpreting new evidence and applying it to individual patients.

Current CME Getaways conference curricula include topics such as atrial fibrillation, anticoagulation management, gastrointestinal bleeding, anemia, and anticoagulation reversal—areas that frequently intersect in hospitalized patients.

For clinicians interested in staying current across these and other inpatient topics, Hospitalist CME conferences provide structured opportunities to review evidence, landmark trials, current guidelines, and practical bedside management.

The Bigger Picture: Hospitalists as Medication-Safety Leaders

The role of the hospitalist continues to expand beyond diagnosing and treating acute illness.

Hospitalists increasingly participate in:

• Patient safety
• Quality improvement
• Medication stewardship
• Care coordination
• Clinical education
• Transitions of care
• Healthcare systems improvement

As we discuss in The Future of the Hospitalist: More Than an Inpatient Physician, hospitalists are increasingly positioned to influence not only individual treatment decisions but also how inpatient care is delivered.

Medication safety is part of that responsibility.

Recognizing potentially unnecessary combination antithrombotic therapy is one example of how careful medication review can potentially reduce avoidable risk.

Bottom Line

Aspirin and anticoagulants can both be valuable medications.

There are patients for whom combination therapy is clinically appropriate.

But combining antiplatelet and anticoagulant therapy can also increase bleeding risk, which means aspirin should not simply remain on a patient’s medication list indefinitely without a current indication.

For hospitalists, the practical lesson is straightforward:

When a patient taking an anticoagulant is also taking aspirin, verify why both medications are being used.

Review the indication.

Review the cardiovascular history.

Review relevant procedures.

Consider bleeding risk.

Review current evidence and guidelines.

And make an individualized decision rather than applying a blanket rule.

Sometimes one of the most important medication decisions a hospitalist makes isn’t what to start.

It’s determining whether a medication still needs to be there.